modified-diallyl disulfide oxide

also known as M-DDO

Developed for: acne
Investigated by: Cell Pharma · Hospital Civil de Guadalajara · University of Guadalajara

today NCT03076320 · Ph 1/2

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT03076320	Mar 2017 → Jan 2019	acne	University of Guadalajara	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	modified-diallyl disulfide oxide	“The other component of Zaxcell is modified-diallyl disulfide oxide (M-DDO) an antimicrobial and antiseptic agent” NCT03076320 ↗
Known as	M-DDO	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03076320 ↗